Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2‐(4,5‐Dihydro‐1H‐imidazol‐2‐yl)‐1‐ methyl‐1H‐indole), for the imidazoline2 binding site
暂无分享,去创建一个
E. Robinson | D. Nutt | A. Hudson | R. Tyacke | S. Husbands | D. Nutt | P. Grundt | C. Parker | A. Fisher | Emma M Turner | Emma M. Turner
[1] Ming-Rong Zhang,et al. In vivo and in vitro imaging of I2 imidazoline receptors in the monkey brain , 2011, Synapse.
[2] Ming-Rong Zhang,et al. Imaging of I2-imidazoline receptors by small-animal PET using 2-(3-fluoro-[4-11C]tolyl)-4,5-dihydro-1H-imidazole ([11C]FTIMD). , 2010, Nuclear medicine and biology.
[3] D. Nutt,et al. Identification of an imidazoline binding protein: Creatine kinase and an imidazoline-2 binding site , 2009, Brain Research.
[4] E. Robinson,et al. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: Evidence for two distinct I2 binding sites , 2007, Neuropharmacology.
[5] S. Barrondo,et al. Opposite changes in imidazoline I2 receptors and alpha2-adrenoceptors density in rat frontal cortex after induced gliosis. , 2005, Life sciences.
[6] C. Dardonville,et al. Imidazoline binding sites and their ligands: An overview of the different chemical structures , 2004, Medicinal research reviews.
[7] L. Callado,et al. Imidazoline I2 receptor density increases with the malignancy of human gliomas , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[8] D. Nutt,et al. Relationship Between Imidazoline2 Sites and Monoamine Oxidase , 2003, Annals of the New York Academy of Sciences.
[9] D. Nutt,et al. Behavioral, neuroendocrine and neurochemical effects of the imidazoline I2 receptor selective ligand BU224 in naive rats and rats exposed to the stress of the forced swim test , 2003, Psychopharmacology.
[10] J. Pineda,et al. Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2‐(2‐benzofuranyl)‐2‐imidazoline in rat locus coeruleus neurons , 2003, British journal of pharmacology.
[11] E. Robinson,et al. Distribution of [(3)H]BU224, a selective imidazoline I(2) binding site ligand, in rat brain. , 2002, European journal of pharmacology.
[12] E. Robinson,et al. 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline2 binding site ligand: in vitro and in vivo characterisation in rat brain , 2002, Neuropharmacology.
[13] D. Nutt,et al. β-carboline binding to imidazoline receptors , 2001 .
[14] D. Nutt,et al. beta-carboline binding to imidazoline receptors. , 2001, Drug and alcohol dependence.
[15] G. Olmos,et al. Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2‐imidazoline receptor ligand LSL 60101 , 2000, British journal of pharmacology.
[16] E. Robinson,et al. Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand. , 2000, Bioorganic & medicinal chemistry letters.
[17] D. Nutt,et al. Novel Selective Compounds for the Investigation of Imidazoline Receptors a , 1999, Annals of the New York Academy of Sciences.
[18] L. Brasili,et al. Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. , 1998, Bioorganic & medicinal chemistry.
[19] M. P. Dillon,et al. 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. , 1998, Trends in pharmacological sciences.
[20] G. Olmos,et al. Attenuation of tolerance to opioid‐induced antinociception and protection against morphine‐induced decrease of neurofilament proteins by idazoxan and other I2‐imidazoline ligands , 1998, British journal of pharmacology.
[21] D. Nutt,et al. Characterisation and localisation of [3H]2-(2-benzofuranyl)-2-imidazoline binding in rat brain: a selective ligand for imidazoline I2 receptors. , 1998, European journal of pharmacology.
[22] C. Bouras,et al. Imidazoline receptor proteins in brains of patients with Alzheimer's disease , 1998, Neuroscience Letters.
[23] G. Olmos,et al. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2‐imidazoline receptors in rat liver , 1997, British journal of pharmacology.
[24] G. Olmos,et al. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[25] L. Brasili,et al. Imidazoline receptors: qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity. , 1997, Bioorganic & medicinal chemistry.
[26] D. Nutt,et al. Identification of ligands selective for central I2-imidazoline binding sites , 1997, Neurochemistry International.
[27] D. Reis,et al. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. , 1996, Archives of general psychiatry.
[28] L. Callado,et al. Increased density of I2-imidazoline receptors in human glioblastomas. , 1996, Neuroreport.
[29] D. Nutt,et al. [3H]2-(2-benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. , 1996, European journal of pharmacology.
[30] G. Reynolds,et al. Imidazoline binding sites in Huntington's and Parkinson's disease putamen. , 1996, European journal of pharmacology.
[31] M. Sastre,et al. Decreased density of I2- imidazoline receptors in the postmortem brains of heroin addicts , 1996, Neuroreport.
[32] D. Nutt,et al. Functional Studies of Specific Imidazoline‐2 Receptor Ligands , 1995, Annals of the New York Academy of Sciences.
[33] N. Morgan,et al. Characterization of the Imidazoline Binding Site Involved in Regulation of Insulin Secretion fn1 , 1995, Annals of the New York Academy of Sciences.
[34] P. Escribá,et al. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain , 1994, British journal of pharmacology.
[35] J. Neumeyer,et al. Visualization of multiple imidazoline/guanidinium-receptive sites. , 1993, The Journal of biological chemistry.
[36] V. Pike. Positron-emitting radioligands for studies in vivo-probes for human psychopharmacology , 1993, Journal of psychopharmacology.
[37] J. Saura,et al. Quantitative enzyme radioautography with 3H-Ro 41-1049 and 3H-Ro 19- 6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[38] F. Tesson,et al. Identification of an imidazoline-guanidinium receptive site in mitochondria from rabbit cerebral cortex. , 1991, European journal of pharmacology.
[39] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[40] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.